We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.
BLPH

Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

17 hedge funds and large institutions have $68.4M invested in Bellerophon Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SBK
Steven B. Klinsky
+$50.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.5M
3
SIG
Senator Investment Group
New York
+$4.66M
4
BBA
Baker Bros. Advisors
New York
+$3.63M
5
HCMT
Highland Capital Management (Texas)
Texas
+$1.68M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SBK
1
Steven B. Klinsky
$44.6M +$50.4M +323,992 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$12M +$13.5M +86,805 New
SIG
3
Senator Investment Group
New York
$4.12M +$4.66M +29,912 New
BBA
4
Baker Bros. Advisors
New York
$3.21M +$3.63M +23,333 New
HCMT
5
Highland Capital Management (Texas)
Texas
$1.49M +$1.68M +10,812 New
CCA
6
Catalyst Capital Advisors
New York
$1.06M +$1.19M +7,667 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$864K +$977K +6,275 New
SM
8
Sabby Management
Florida
$275K +$311K +2,000 New
Morgan Stanley
9
Morgan Stanley
New York
$194K +$219K +1,409 New
Goldman Sachs
10
Goldman Sachs
New York
$159K +$179K +1,153 New
Millennium Management
11
Millennium Management
New York
$142K +$160K +1,028 New
BG
12
BlackRock Group
United Kingdom
$133K +$151K +969 New
BIT
13
BlackRock Institutional Trust
California
$125K +$141K +904 New
UBS Group
14
UBS Group
Switzerland
$13K +$15.1K +97 New
BIM
15
BlackRock Investment Management
Delaware
$8K +$8.72K +56 New
BA
16
BlackRock Advisors
Delaware
$3K +$3.27K +21 New
TRCT
17
Tower Research Capital (TRC)
New York
$3K +$3.42K +22 New

BLPH Hedge Fund Activity: Q1 2015 in Review

17 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q1 2015, worth a combined $68.4M.

Buyers outnumbered sellers: 17 funds opened new BLPH positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Steven B. Klinsky, opening a new position worth an estimated $50.4M.

  • 17 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q1 2015, up from 0 in Q4 2014.
  • Funds reported $68.4M of Bellerophon Therapeutics, Inc. stock for Q1 2015.
  • 17 funds opened new Bellerophon Therapeutics, Inc. positions in Q1 2015 and 0 closed out, a net change of +17 holders.
  • The largest Bellerophon Therapeutics, Inc. buyer in Q1 2015 was Steven B. Klinsky, an estimated $50.4M added.

Based on aggregated 13F filings for Q1 2015.